Postponed: The Investment Readiness Series – Israel Edition

Biocat, Inveniam Group

Note: the organization postpones the event.

A new edition of The Investment Readiness Series – Israel Edition is taking place on May 10 in Tel-Aviv. This initiative led by Biocat in collaboration with Inveniam and ACCIÓ Tel-Aviv aims to put Catalan biotech companies and innovative healthcare projects in contact with relevant investors, accelerators and incubators from the Israeli ecosystem.

Israel is widely regarded as one of the world leaders in innovation in healthcare and life sciences. Its solid and dynamic network of researchers, entrepreneurs and investors has led it to become one of the most fertile and innovative life sciences ecosystems in the world.

The event will consist of two parallel sessions:

• Investors track: where the most promising biotech and pharma companies seeking for seed capital or Series A investment will:
  1) pitch in front of an audience of 4-7 Israeli investors and venture capitals and
  2) hold 30' private meetings with those interested in them.

• Licensing/acceleration track:  where healthcare innovative projects (biotech, medtech and digital health) ready to explore collaboration and licensing opportunities will:
  1) pitch in front of an audience of 4-7 accelerators, incubators and early-stage investors and
  2) hold 30' private meetings with those interested in them.

More Information:

• Register for free

• Call open until March 10

Organizers:
            


Collaborator: